List of insiders holdings for Retension Pharmaceuticals, Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Keller Eric L. CHIEF EXECUTIVE OFFICER | 2026-10-14 16:05:57 | 598,598 0 | 598,598 | Form 13D |
| 2 | Sweetnam Paul CHIEF SCIENTIFIC OFFICER | 2026-10-13 18:12:09 | 406,603 2,640 | 409,243 | Form 4 |
| 3 | Schecter Alison D. Chief Medical Officer | 2026-10-08 18:37:19 | 152,980 0 | 152,980 | Form 3 |
| 4 | Schwartz Alexander Duke Chief Financial Officer | 2026-10-08 18:38:27 | 64,413 0 | 64,413 | Form 3 |
| 5 | BERGER FRANKLIN M Director | 2026-10-13 18:10:58 | 12,517 10,000 | 22,517 | Form 4 |
| 6 | BERENDT MICHAEL J Director | 2026-10-13 18:10:41 | 6,666 0 | 6,666 | Form 4 |
| 7 | Olds Donald Director | 2026-10-13 18:11:52 | 5,637 0 | 5,637 | Form 4 |
| 8 | Cheruvu Pavan Director | 2026-10-13 18:11:36 | 5,636 0 | 5,636 | Form 4 |
| 9 | Bisson Sabine CHIEF OPERATING OFFICER | 2026-10-13 18:11:18 | 4,115 0 | 4,115 | Form 4 |